:@0.120969:0.065467:0.126105:0.065467:0.126105:0.050897:0.120969:0.050897:0.005136
Timetable of the Research Proposal Presentation and :@0.120969:0.401746:0.566271:0.401746:0.566271:0.387176:0.120969:0.387176:0.011399:0.003695:0.015778:0.010401:0.005044:0.010401:0.010401:0.003695:0.010517:0.005039:0.010401:0.005044:0.005044:0.005044:0.010401:0.010401:0.005059:0.013413:0.010069:0.009385:0.010401:0.010401:0.005709:0.009385:0.010401:0.005044:0.012415:0.006041:0.010069:0.010401:0.010401:0.009071:0.010401:0.003695:0.005044:0.012415:0.006041:0.010401:0.009385:0.010401:0.010401:0.005044:0.010401:0.005044:0.003695:0.010401:0.010744:0.005039:0.010413:0.010413:0.010413:0.005136
Review of Researches.:@0.566174:0.401646:0.747559:0.401646:0.747559:0.387606:0.566174:0.387606:0.012765:0.009400:0.009044:0.003703:0.009738:0.012427:0.005020:0.009738:0.005020:0.005139:0.012765:0.009738:0.009044:0.009738:0.009738:0.006035:0.009044:0.009400:0.009738:0.009199:0.004949
 :@0.747313:0.401746:0.752449:0.401746:0.752449:0.387176:0.747313:0.387176:0.005136
 :@0.120969:0.430732:0.126105:0.430732:0.126105:0.416162:0.120969:0.416162:0.005136
Activity :@0.182768:0.140580:0.246402:0.140580:0.246402:0.126010:0.182768:0.126010:0.012415:0.009385:0.005044:0.003695:0.009718:0.003695:0.005044:0.009503:0.005136
Date of :@0.375344:0.133215:0.440228:0.133215:0.440228:0.118645:0.375344:0.118645:0.013413:0.010401:0.005044:0.010401:0.005044:0.010401:0.005044:0.005136
Presentation :@0.353510:0.148171:0.462425:0.148171:0.462425:0.133601:0.353510:0.133601:0.012415:0.006041:0.010401:0.009385:0.010069:0.010401:0.005044:0.010401:0.005044:0.003695:0.010401:0.010480:0.005136
Deadline of :@0.541317:0.125600:0.639751:0.125600:0.639751:0.111030:0.541317:0.111030:0.013413:0.010401:0.010069:0.010401:0.004028:0.003695:0.010401:0.010401:0.005044:0.010401:0.005044:0.005136
Submission of :@0.529896:0.140580:0.651147:0.140580:0.651147:0.126010:0.529896:0.126010:0.012415:0.010401:0.010069:0.015778:0.003695:0.009385:0.009385:0.003695:0.010401:0.010401:0.005044:0.010401:0.005044:0.005136
Research proposal :@0.510413:0.155785:0.670789:0.155785:0.670789:0.141215:0.510413:0.141215:0.013413:0.010401:0.009071:0.010401:0.010401:0.006041:0.009071:0.010401:0.005044:0.010401:0.006041:0.010401:0.010069:0.010401:0.009071:0.010401:0.004207:0.005136
Deadline of :@0.718038:0.118009:0.816473:0.118009:0.816473:0.103439:0.718038:0.103439:0.013413:0.010401:0.010069:0.010401:0.004028:0.003695:0.010401:0.010401:0.005044:0.010401:0.005044:0.005136
Submission of On-:@0.688831:0.133215:0.841137:0.133215:0.841137:0.118645:0.688831:0.118645:0.012415:0.010401:0.010069:0.015778:0.003695:0.009385:0.009385:0.003695:0.010401:0.010401:0.005180:0.010401:0.005044:0.005045:0.014444:0.010413:0.006152
going or Terminal :@0.693198:0.148171:0.841663:0.148171:0.841663:0.133601:0.693198:0.133601:0.010401:0.010401:0.003695:0.010401:0.010401:0.005044:0.010401:0.006041:0.005044:0.011085:0.010401:0.006041:0.015778:0.003695:0.010401:0.010401:0.003695:0.005136
Report :@0.737235:0.163139:0.797796:0.163139:0.797796:0.148569:0.737235:0.148569:0.013413:0.010401:0.010069:0.010401:0.006041:0.005099:0.005136
Research Proposal :@0.120969:0.234212:0.283161:0.234212:0.283161:0.219642:0.120969:0.219642:0.013413:0.010401:0.009071:0.010401:0.010401:0.006041:0.009071:0.010401:0.005044:0.012415:0.006041:0.010401:0.010069:0.010401:0.009385:0.010401:0.003695:0.005136
Presentation :@0.120969:0.249180:0.229943:0.249180:0.229943:0.234610:0.120969:0.234610:0.012415:0.006041:0.010401:0.009385:0.010069:0.010401:0.005044:0.010401:0.005044:0.003695:0.010401:0.010539:0.005136
March 16, 2021 :@0.321549:0.188085:0.455052:0.188085:0.455052:0.173515:0.321549:0.173515:0.015113:0.010401:0.006041:0.009385:0.010401:0.005044:0.010401:0.010401:0.005044:0.005044:0.010401:0.010401:0.010069:0.010220:0.005136
March 4, 2021 :@0.507726:0.188085:0.631152:0.188085:0.631152:0.173515:0.507726:0.173515:0.015113:0.010401:0.006041:0.009385:0.010401:0.005044:0.010401:0.005044:0.005044:0.010401:0.010401:0.010401:0.010212:0.005136
  :@0.686127:0.188085:0.696302:0.188085:0.696302:0.173515:0.686127:0.173515:0.005039:0.005136
Aril 27, 2021 :@0.321549:0.222096:0.430514:0.222096:0.430514:0.207526:0.321549:0.207526:0.012415:0.006041:0.004028:0.004028:0.005044:0.010401:0.010401:0.005044:0.005044:0.010401:0.010401:0.010401:0.010180:0.005136
April 5, 2021 :@0.507726:0.222096:0.616708:0.222096:0.616708:0.207526:0.507726:0.207526:0.012415:0.010401:0.006041:0.004028:0.003695:0.005044:0.010401:0.005044:0.005044:0.010401:0.010401:0.010401:0.010529:0.005136
  :@0.686127:0.222096:0.696302:0.222096:0.696302:0.207526:0.686127:0.207526:0.005039:0.005136
July 6, 2021 :@0.321549:0.258684:0.426500:0.258684:0.426500:0.244114:0.321549:0.244114:0.009385:0.010401:0.003695:0.009071:0.005044:0.010401:0.005044:0.005044:0.010401:0.010401:0.010401:0.010526:0.005136
June 6, 2021 :@0.507726:0.258684:0.619714:0.258684:0.619714:0.244114:0.507726:0.244114:0.009385:0.010401:0.010069:0.010401:0.005044:0.010401:0.005044:0.005044:0.010401:0.010069:0.010401:0.010191:0.005136
  :@0.686127:0.258684:0.696302:0.258684:0.696302:0.244114:0.686127:0.244114:0.005039:0.005136
Nov. 9, 2021 :@0.321549:0.295510:0.431538:0.295510:0.431538:0.280940:0.321549:0.280940:0.013413:0.010069:0.009718:0.005044:0.005044:0.010401:0.005044:0.005044:0.010401:0.010069:0.010401:0.010207:0.005136
October 9, 2021 :@0.507726:0.295510:0.645260:0.295510:0.645260:0.280940:0.507726:0.280940:0.014429:0.009385:0.005044:0.010401:0.010069:0.010401:0.006041:0.005044:0.010401:0.005044:0.005044:0.010401:0.010401:0.010069:0.010223:0.005136
  :@0.686127:0.295510:0.696302:0.295510:0.696302:0.280940:0.686127:0.280940:0.005039:0.005136
In-house Review of :@0.120969:0.323683:0.276603:0.323683:0.276603:0.309642:0.120969:0.309642:0.005039:0.009405:0.006046:0.009738:0.010059:0.009400:0.009044:0.009738:0.005020:0.012765:0.009738:0.009044:0.003703:0.009738:0.012427:0.005020:0.009738:0.005020:0.004949
On-going Researches :@0.120969:0.337962:0.297610:0.337962:0.297610:0.323921:0.120969:0.323921:0.013772:0.009405:0.006046:0.010059:0.009738:0.004006:0.009400:0.010059:0.005020:0.012765:0.009738:0.009044:0.009738:0.009738:0.005715:0.009044:0.009400:0.009738:0.009264:0.004949
June 8-9, 2021 :@0.321549:0.330810:0.444116:0.330810:0.444116:0.316770:0.321549:0.316770:0.009044:0.009738:0.009400:0.009826:0.005039:0.009741:0.006046:0.009738:0.005020:0.005020:0.009738:0.009738:0.009738:0.009790:0.004949
  :@0.507726:0.331385:0.517901:0.331385:0.517901:0.316815:0.507726:0.316815:0.005039:0.005136
May 25, 2021 :@0.686127:0.331385:0.803171:0.331385:0.803171:0.316815:0.686127:0.316815:0.015113:0.010401:0.009071:0.005044:0.010401:0.010401:0.005044:0.005044:0.010401:0.010401:0.010401:0.010185:0.005136
In-house Review of :@0.120969:0.357218:0.276603:0.357218:0.276603:0.343178:0.120969:0.343178:0.005039:0.009405:0.006046:0.009738:0.010059:0.009400:0.009044:0.009738:0.005020:0.012765:0.009738:0.009044:0.003703:0.009738:0.012427:0.005020:0.009738:0.005020:0.004949
Completed :@0.120969:0.371473:0.211195:0.371473:0.211195:0.357433:0.120969:0.357433:0.012765:0.009738:0.015097:0.009738:0.003703:0.009738:0.005020:0.009738:0.009738:0.004949
Researches :@0.120969:0.385954:0.220015:0.385954:0.220015:0.371914:0.120969:0.371914:0.012765:0.009738:0.009044:0.009738:0.009738:0.005715:0.009044:0.009400:0.009738:0.009175:0.004949
Nov. 16-17, 2021 :@0.321549:0.371473:0.461919:0.371473:0.461919:0.357433:0.321549:0.357433:0.012765:0.009738:0.009044:0.005020:0.005020:0.009738:0.009523:0.006030:0.009738:0.009738:0.005020:0.005020:0.009738:0.009738:0.009738:0.009810:0.004949
  :@0.507726:0.372048:0.517901:0.372048:0.517901:0.357478:0.507726:0.357478:0.005039:0.005136
November 2, 2021 :@0.686127:0.372048:0.843144:0.372048:0.843144:0.357478:0.686127:0.357478:0.013413:0.010069:0.009385:0.010069:0.015778:0.010069:0.010401:0.006041:0.005044:0.010401:0.005044:0.005044:0.010401:0.010401:0.010069:0.010252:0.005136